Opicinumab Biosimilar – Anti-LINGO1, LRRN6A, LERN1 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameOpicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb - Research Grade
SourceCAS 1422268-07-2
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsOpicinumab,BIIB-033,LINGO1, LRRN6A, LERN1,anti-LINGO1, LRRN6A, LERN1
ReferencePX-TA1389
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb - Research Grade

General information on Anti-LINGO1/LRRN6A/LERN1[Homo sapiens] (Opicinumab) Monoclonal Antibody

Opcinumab is investigated for the treatment of Central Nervous System (CNS) Demyelinating Disease and Multiple Sclerosis.

SDS-PAGE for Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb

Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Opicinumab Biosimilar – Anti-LINGO1, LRRN6A, LERN1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products